| | | | | |
AMPH Amphastar Pharmaceuticals, Inc. | €17,1907 | +0,10 % | €839,72M | €118,55K | |
REPL Replimune Group, Inc. | €10,1256 | +0,00 % | €839,70M | €1,13M | |
| €50,0507 | +0,00 % | €837,48M | €122,89K | |
AIO Virtus Artificial Intelligence & Technology Opportunities Fund | €23,6438 | +0,00 % | €836,85M | €55,95K | |
AVTX Avalo Therapeutics, Inc. Common Stock | €16,2026 | -1,65 % | €836,53M | €1,42M | |
HSLV Highlander Silver Corp. | €4,3720 | +0,00 % | €836,00M | €365,87K | |
| €47,7116 | +0,05 % | €835,20M | €33,67K | |
SANA Sana Biotechnology, Inc. Common Stock | €3,5063 | +0,00 % | €832,21M | €2,20M | |
ABX Abacus Global Management, Inc. | €10,3704 | +0,00 % | €831,19M | €443,74K | |
ANRO Alto Neuroscience Inc. | €21,6676 | +0,00 % | €829,75M | €333,20K | |
GDRX GoodRx Holdings, Inc. Class A Common Stock | €2,6757 | +0,33 % | €829,18M | €1,10M | |
RHLD Resolute Holdings Management, Inc. | €129,71 | +0,00 % | €829,18M | €40,88K | |
BTZ BlackRock Credit Allocation Income Trust | €8,9713 | +0,00 % | €829,08M | €56,78K | |
DBVT DBV Technologies S.A. | €13,8243 | -0,06 % | €828,56M | €165,94K | |
PHAR Pharming Group N.V. ADS, each representing 10 ordinary shares | €11,9137 | -1,05 % | €828,13M | €3,78K | |
